Skip to content
10-Q

Quarterly Report

Wellgistics Health, Inc. WGRX

0001493152-26-024413

← back to feed
Filed
May 19, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2026 · May 19, 2026 125.67M sh
Shares Diluted Q1 2026 · Mar 31, 2026 104.62M sh
Shares Diluted Q1 2026 · Mar 31, 2025 51.92M sh
Operating Cash Flow Q1 2026 · Mar 31, 2026 −$3.41M
Operating Cash Flow Q1 2026 · Mar 31, 2025 −$1.35M
Long Term Debt Q1 2026 · Mar 31, 2026 $12.6M
Long Term Debt Q1 2026 · Dec 31, 2025 $12.6M
Short Term Debt Q1 2026 · Mar 31, 2026 $15.17M
Short Term Debt Q1 2026 · Dec 31, 2025 $10.89M
Cash And Equivalents Q1 2026 · Mar 31, 2026 $51.73K
Cash And Equivalents Q1 2026 · Dec 31, 2025 $42.57K
Stockholders Equity Q1 2026 · Mar 31, 2026 −$15.06M
Stockholders Equity Q1 2026 · Dec 31, 2025 −$12.45M
Stockholders Equity Q1 2026 · Mar 31, 2025 $4.48M
Stockholders Equity Q1 2026 · Dec 31, 2024 $6.73M
Current Liabilities Q1 2026 · Mar 31, 2026 $32.2M
Current Liabilities Q1 2026 · Dec 31, 2025 $29.78M
Total Liabilities Q1 2026 · Mar 31, 2026 $45.19M
Total Liabilities Q1 2026 · Dec 31, 2025 $42.91M
Current Assets Q1 2026 · Mar 31, 2026 $2.76M
Current Assets Q1 2026 · Dec 31, 2025 $2.82M
Total Assets Q1 2026 · Mar 31, 2026 $30.13M
Total Assets Q1 2026 · Dec 31, 2025 $30.46M
Eps Diluted Q1 2026 · Mar 31, 2026 −$0.07
Eps Diluted Q1 2026 · Mar 31, 2025 −$0.62
Eps Basic Q1 2026 · Mar 31, 2026 −$0.07
Eps Basic Q1 2026 · Mar 31, 2025 −$0.62
Sga Expense Q1 2026 · Mar 31, 2026 $4.87M
Sga Expense Q1 2026 · Mar 31, 2025 $31.17M
Net Income Q1 2026 · Mar 31, 2026 −$7.74M
Net Income Q1 2026 · Mar 31, 2025 −$32.43M
Operating Income Q1 2026 · Mar 31, 2026 −$6.02M
Operating Income Q1 2026 · Mar 31, 2025 −$31.35M
Gross Profit Q1 2026 · Mar 31, 2026 $170.22K
Gross Profit Q1 2026 · Mar 31, 2025 $692.64K
Cost Of Revenue Q1 2026 · Mar 31, 2026 $1.39M
Cost Of Revenue Q1 2026 · Mar 31, 2025 $10.17M
Revenue Q1 2026 · Mar 31, 2026 $1.56M
Revenue Q1 2026 · Mar 31, 2025 $10.86M